XB-PHENO-16576
Xla Wt + spry2 MO, Sun J et al. (2020)
Experiment + Assay: |
Xla Wt + spry2 MO +
NF 19 (immunohistochemistry)
|
Manipulations: |
Manipulation Type |
Reagent |
Target Gene |
Stage |
Treatment Area |
morpholino injection
|
spry2 MO3
|
spry2 (Xla)
|
NF stage 32
|
blastomere D1.1.1
|
|
Conditions: |
Assay Type |
Assay Stages |
Antibody |
immunohistochemistry
|
NF stage 19
to NF stage 19
|
|
|
|
Expression Phenotypes (2):
|
decreased amount
pax6.L
expression in eye primordium
|
decreased amount
rax.L
expression in eye primordium
|
|
Source:
Fig. 5 r1c2, r2c2